GlassScriptPhysician profile
William Brett Boring
NPI 1376776815
$717.58
in general payments reported to CMS, 2019-2025
10 companies · $38.62 in 2025
The $38.62 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.35 · 2022: $54.09 · 2023: $307 · 2024: $303 · 2025: $38.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $648.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $162.26 | 2023-2025 | Attune, Monovisc, Orthovisc |
| Ferring Pharmaceuticals INC. | $157.05 | 2021-2023 | Euflexxa |
| E.R. Squibb & Sons, L.L.C. | $135.71 | 2022-2024 | Eliquis |
| Si-Bone, INC. | $87.71 | 2024 | |
| Heron Therapeutics, INC. | $57.09 | 2024 | Zynrelef |
| Vericel Corporation | $37.01 | 2024 | Maci |
| Convatec INC. | $27.45 | 2022 | |
| Bioventus LLC | $23.43 | 2025 | Durolane |
| Abbott Laboratories | $17.90 | 2023 | Axium |
| Boston Scientific Corporation | $11.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Boring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.